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Abstract
Objectives—The aim of this study is to examine the difference in the report of bodily pain
experienced by subjects who develop temporomandibular disorders (TMD) and by those who do not
develop TMD over a 3 year observation period.
Methods—This is a 3 year prospective study of 266 females aged 18–34 years initially free of TMD
pain. All subjects completed the Symptom Report Questionnaire (SRQ) at baseline and yearly
intervals, and at the time they developed TMD (if applicable). The SRQ is a self-report instrument
evaluating the extent and location of pain experienced in the prior 6 months. Statistical analysis was
carried out using repeated measures ANOVA.
Results—Over the 3 year period, 16 subjects developed TMD based on the Research Diagnostic
Criteria for TMD. Subjects who developed TMD reported more headaches (P=0.0089), muscle
soreness or pain (P=0.005), joint soreness or pain (P=0.0012), back pain (P=0.0001), chest pain
(P=0.0004), abdominal pain (P=0.0021), and menstrual pain (P=0.0036) than subjects who did not
develop TMD at both the baseline and final visits. Subjects who developed TMD also reported
significantly more headache (P=0.0006), muscle soreness or pain (P=0.0059), and other pains
(P=0.0188) when they were diagnosed with TMD compared to the baseline visit.
Discussion—The development of TMD was accompanied by increases in headaches, muscle
soreness or pain, and other pains that were not observed in the subjects who did not develop TMD.
Subjects who developed TMD also report higher experience of joint, back, chest and menstrual pain
at baseline.
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Chronic pain is rarely present in a single body site. Three distinct patterns of pain distribution,
namely, localized, regional, and widespread pain has been described 1 2. Heterogeneous pain
symptoms are believed to share common neurophysiologic, psychological, and behavioral
mechanisms independent of specific differences in peripheral injury or disease 3.
Epidemiological and clinical trials have also provided consistent evidence that regional and
widespread chronic pain conditions should be considered as part of a “continuum” rather than
distinct entities with distinct etiologies 1 4. Therefore, it is likely that there are some areas of
shared risk exposure for all these pain conditions, implying that perhaps the face may be just
one body region involved in a more widespread pain syndrome 5. Various studies have since
reported that facial pain is comorbid with widespread bodily pain 6 7 5 8 9.
Temporomandibular disorders (TMD) is a collective term used to describe a number of related
disorders involving the temporomandibular joints, masticatory muscles, and related structures
10. Emerging evidence suggests a significant overlap between TMD states and pain conditions
in other parts of the body, such as headaches, and neck, shoulder, and back pain 2 11 12 5 13.
Studies have also reported comorbidity between TMD and fibromyalgia 14 15, and that these
two conditions seemed to have in common numerous clinical symptoms, such as generalized
pain sensitivity 4. Therefore, TMD may represent one manifestation of a more global pain
sensitivity disorder 4. In addition, co-occurring pain conditions in TMD patients may
potentially influence the course of pain and associated psychological disturbance and
psychosocial dysfunction in these patients 16 17.
Widespread pain has been cited as one of the risk factors for the persistence of TMD pain 7.
Subjects with chronic TMD reported a greater number of body sites with pain than subjects
with remitted or recurrent TMD 18. Furthermore, subjects with frequent headaches or pain in
other parts of the body had a threefold increase in risk of having TMD 5. In women without
dysfunctional TMD pain at baseline, widespread pain was a risk factor for the development of
dysfunctional TMD pain 19. Widespread pain was also highly associated with the risk of
developing pain-related disability in female TMD patients 19. Recent studies have shown that
widespread pain is also a risk factor for the development or onset of TMD pain. Von Korff et
al reported that the presence of a pain condition at baseline was a more consistent predictor of
subsequent risks of developing TMD than was the severity or chronicity of depressive
symptoms 20. In a prospective study, LeResche et al 21 reported that the probability of
developing TMD in early adolescence increased with the report of other pain conditions at
baseline.
Associations reported by cross-sectional studies are not necessarily risk factors. They could be
a consequence of having symptoms 22. Longitudinal studies are more useful in examining the
risk factors that are predictive of the onset of TMD 13 4. However, few longitudinal studies
have employed frequent follow ups in assessing the onset of pain conditions. The aim of this
study was to examine the difference in the report of bodily pain experienced by subjects who
develop TMD and by those who do not develop TMD over a 3 year observation period. This
will allow further understanding of the temporal relationship linking the development of
various pain symptoms.
Materials and Methods
This is a 3 year prospective study of 266 females aged 18–34 years initially free of TMD pain.
Subjects were recruited by advertisements placed in local newspapers for a study designed to
examine the relationship between pain sensitivity and the development of TMD. During the
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study visits (at baseline and at yearly intervals for 3 years), subjects completed questionnaires
which identified self-reported facial pain and TMD symptoms and underwent a physical
examination of the head and neck conducted according to the RDC for TMD 23. Individuals
were excluded if they had a history of TMD or were diagnosed with TMD at the baseline
examination. In addition to these study visits, online health surveys, which included questions
on facial pain and TMD symptoms, were completed by the participants every 3 months over
the 3 year period. Following each survey, participants who responded positively to key
questions about facial pain and TMD symptoms were recalled for a re-examination according
to the RDC protocol. New cases of TMD were defined according to the RDC for Group I
Myofascial Pain and/or Group III Arthralgia, both of which included reported pain and pain
on palpation 23. New cases were confirmed independently by two examiners.
All subjects completed the Symptom Report Questionnaire (SRQ) (Figure 1) at baseline and
yearly intervals, and at the time they developed TMD (if applicable). The SRQ is a self-report
instrument evaluating the extent and location of pain experienced in the prior 6 months.
Statistical analysis was carried out using repeated measures ANOVA.
Results
Over the 3 year period, 16 subjects (6%) developed TMD (based on the RDC for TMD23).
The participation rate at subsequent yearly follow-up was 69.9% (186 subjects), 55.3% (147
subjects), and 71.1% (189 subjects) at the first, second, and third years respectively.
Subjects who developed TMD reported more headaches (P=0.0089), muscle soreness or pain
(P=0.005), joint soreness or pain (P=0.0012), back pain (P=0.0001), chest pain (P=0.0004),
abdominal pain (P=0.0021), and menstrual pain (P=0.0036) than subjects who did not develop
TMD at both the baseline and the final visits (Figure 2).
Subjects who developed TMD reported significantly more headache (P=0.0006), muscle
soreness or pain (P=0.0059), and other pains (P=0.0188) when they were diagnosed with TMD
compared to the baseline visit (Figure 3).
Discussion
In this study, the 3-year cumulative incidence rate of TMD was 6%. This is similar to previous
report of 3-year TMD onset rate of 6.5% 20. Similarly, the onset rate of widespread pain in
longitudinal studies involving subjects with no initial pain was estimated to be between 2% to
10% 24 25, while the point prevalence of chronic widespread pain in a general population sample
was about 11.2% 26. The pain conditions examined by previous studies included headaches,
back pain, chest pain, joint pain, and abdominal pain 20 21. In this study we included muscle
soreness or pain, pelvic pain, and menstrual pain. Menstrual pain reported by all subjects in
this study seemed to decrease over the observation period. One possible reason for this is that
the experience of menstrual pain at baseline was considerably higher than the experience of
the other pains, such as chest or pelvic pain. Therefore this may reflect a reduction in extent
of menstrual pain experienced.
Von Korff et al 20 and LeResche et al 21 reported that widespread pain is a risk factor associated
with the onset of TMD. In this study subjects who developed TMD reported higher experience
of joint, back, chest and menstrual pain at baseline compared to those subjects who did not
develop TMD. Similarly, Korszun et al reported that 67% of their cohort of TMD subjects
reported an onset of generalized pain symptoms before the onset of facial pain 15. Bergman et
al also reported that the development of CWP from no chronic pain or chronic regional pain
over a 3-year follow-up period was predicted by the number of painful regions at baseline 27.
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Various other psychological and social risk factors have also been identified as risk factors for
the future development of CWP, including greater impairment of general health status, sleep
disturbance, fatigue, and high psychological distress 28 29 30 31 32 33. Paralleling the
development of CWP, co-occurring physical symptoms, often referred to as somatization
symptoms, function as potential significant prognosticators of the future clinical course in these
patients 34 16. However, the most important clinical risk factor for chronic pain at a specific
site appears to be pain 35. Von Korff et al reported that the presence of a pain condition at
baseline was a more consistent predictor of subsequent risks of developing a new pain condition
than was the severity of chronicity of depressive symptoms 20. In fact, the presence of one pain
condition at baseline has been shown to be associated with a 4 times increased risk of
developing TMD 20. These findings are in agreement with various case-control studies which
have suggested that it seems inappropriate to consider TMD in isolation 5. Rather, regional
and widespread chronic pain conditions represent “overlapping” conditions, and should be
considered as part of a “continuum” than distinct entities with distinct etiologies 1 4. That being
said, there are also other risk factors unique to the development of TMD such as bruxism,
history of facial trauma, and third-molar extraction 5 36, which may not present as significant
risk factors for the development of pain in other areas of the body.
In this study the onset of TMD was accompanied by increases in headache, muscle, and other
pains which were not reported in the group that did not develop TMD. Macfarlane et al reported
that subjects with headaches had a threefold increase in risk of having TMD. However, having
pain in parts of the body other than the head also lead to a threefold increase in risk of having
TMD 5. Their data suggested that perhaps TMD and headache may share common etiological
factors, rather than that pain at one specific site altered the risk of developing pain at another
specific site. On the contrary, Von Korff et al studied the onset rates of back pain, headaches,
chest pain, abdominal pain, and TMD, and found that the risk of onset of TMD was not
significantly increased by the presence of any specific pain condition 20.
From a clinical perspective, the occurrence of TMD with widespread body pain may impact
the management of such patients. Raphael et al reported that TMD patients with widespread
pain did not improve with occlusal splint therapy compared to those with just local pain 37.
Future studies need to address the impact of widespread body pain on the prognosis of the
various treatment modalities for TMD.
Our study had several strengths. The participation rate at subsequent follow-up was moderately
high. We used reliable criterion-based examination (RDC for TMD) for the diagnosis of TMD
for all subjects 23. Self-reported facial pain symptoms were obtained quarterly and this has
been recommended to be a reasonably accurate recall period reducing response bias 20 32 38.
The longitudinal design employed in this study allowed us to investigate the temporal
relationship sequence linking the development of various pain symptoms, namely that
widespread pain was reportedly present prior to the onset of TMD, and that the onset of TMD
accompanied by reportedly greater experience of widespread pain.
Several limitations of this study also deserve mention. Males were excluded in this study
because the female gender has been reported to be a TMD risk factor 39. Future studies need
to investigate the relationship between widespread pain and the development of TMD in men.
Our reliance on self-reported body pain symptoms based on a questionnaire (SRQ) is subject
to recall bias 40. Alternative methods of data collection, such as using daily diary, will avoid
such bias. Moreover, although three monthly symptom report has been previously
recommended 20 32, our subjects reported body pain symptoms experienced over the last six
months. It has also been argued that the location and extent of chronic body pain are best
determined by physical examination by a qualified practitioner. However, since pain is a
subjective experience, the practitioner would still have to rely on patient self-report. Finally,
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this study examined only the pain experience associated with the onset of TMD. It is our
intention to continue to track these subjects to determine chronicity.
Conclusions
In this 3 year prospective study of 266 females aged 18–34 years initially free of TMD pain,
16 subjects (6%) developed TMD. The development of TMD was accompanied by increases
in headaches, muscle soreness or pain, and other pains that were not observed in the subjects
who did not develop TMD. Subjects who developed TMD also report higher experience of
joint, back, chest and menstrual pain at baseline compared to those subjects who did not develop
TMD.
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Pain reported by subjects over a 3 year observation period. The SRQ score `0.5' codes for `not
at all'; `1.0' codes for `a little bit'; `1.5' codes for `a moderate amount'; `2.0' codes for `quite a
bit'; and `2.5' codes for `an extreme amount'.
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Pain reported by subjects who developed TMD (at study baseline and at TMD onset) and by
subjects who did not develop TMD (at study baseline and at final visit). The SRQ score `0.5'
codes for ̀ not at all'; ̀ 1.0' codes for ̀ a little bit'; ̀ 1.5' codes for ̀ a moderate amount'; ̀ 2.0' codes
for `quite a bit'; and `2.5' codes for `an extreme amount'.
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